A dietary intervention for chronic diabetic neuropathy pain: a randomized controlled pilot study.
A E Bunner, C L Wells, J Gonzales...
https://pubmed.ncbi.nlm.nih.gov/26011582/Actively Recruiting
Led by AdventHealth · Updated on 2026-04-30
40
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating whether targeted changes in diet can improve symptoms of painful diabetic neuropathy PDN, a condition caused by reduced blood flow and oxygen to peripheral nerves leading to nerve damage. This randomized controlled trial compares the effects of a whole-food, plant-based diet without added oils to standard medication management for PDN. The study aims to better understand if dietary changes can enhance nerve function and reduce pain in people with type 2 diabetes-related neuropathy. Participants will be randomly assigned to one of two groups a diet group following a whole-food, plant-based diet excluding all meat, dairy, eggs, and added oils, and a medication group receiving optimized pharmacologic treatment including drugs like gabapentin, pregabalin, duloxetine, and others. The diet group may also attend optional cooking classes to support adherence. After two months, those in the medication group can choose to switch to the diet intervention, with further outcomes assessed. During the study, participants will have regular assessments including pain ratings using the Numerical Rating Scale, evaluations of numbness, sleep quality, medication use, and function. Researchers will monitor health measures such as weight, blood pressure, heart rate, blood labs including hemoglobin A1c and lipid levels, and compliance with the diet. The primary outcome focuses on pain improvement after two months of intervention. The total study duration includes initial treatment and possible crossover periods with follow-up visits to track changes and safety.
CONDITIONS
The Treatment of Painful Diabetic Neuropathy With Diet
W
William J Beckworth, MD
M
Mary Stanford, Clinical Research Coordinator
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
AdventHealth
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Plant-based dietary intervention | Medication optimization for neuropathy |
|---|---|---|
| What it is | A structured plant-based dietary regimen, provided and monitored as a clinical intervention for eligible adults with painful diabetic neuropathy and type 2 diabetes or pre-diabetes. | Medical management consists of pharmacological optimization for neuropathic pain, based on clinical practice for painful diabetic neuropathy. |
| Role in trial | Assigned to participants as one intervention period in the crossover trial; evaluated for its effect on neuropathic pain, numbness, sleep, and diabetes control. | Serves as the comparator intervention period in the crossover trial; measured against diet for changes in pain, numbness, and diabetes outcomes. |
| Primary use | Diet is studied for reduction of neuropathic pain and improvement in glycemic control, targeting symptom relief and functional outcomes for diabetic neuropathy. | Medication optimization aims to reduce neuropathic pain and improve diabetic management through evidence-based pharmacological treatment. |
| How it is given or performed | Participants follow a prescribed plant-based meal plan, with monitoring and support throughout the study period. | Participants receive optimized prescriptions for diabetes and neuropathic pain medications, managed and adjusted by clinical providers. |
| Evidence status | Literature indicates plant-based diets may improve pain and glycemic outcomes in diabetes, though evidence for neuropathy pain relief is still emerging. Controlled pilot studies and meta-analyses have reported moderate efficacy, but confirmatory large-scale trials are limited. | Medication-based management for diabetic neuropathy pain is supported by broad guideline recommendations and randomized trials. There is robust evidence for modest pain reduction, but many patients experience partial relief and side effects. |
| Important limitations | Dietary adherence may be challenging for some participants, and the clinical evidence for pain reduction is limited to small studies and early trials. Long-term impact and comparative effectiveness versus medication are not yet established. | Medication optimization may offer only partial pain control, with potential side effects and varying effectiveness across individuals. Chronic management may require ongoing adjustments, and optimal regimens differ by patient. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 2 months
Participants follow either a whole-food, plant-based diet excluding all animal products and added oils or receive conventional medical management with optimized pharmacologic therapy to manage painful diabetic neuropathy.
1 baseline visit and 1 follow-up visit
Duration - Additional period after initial 2 months
Participants initially receiving conventional medical management may cross over to the dietary intervention with additional outcomes assessed following crossover.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
A E Bunner, C L Wells, J Gonzales...
https://pubmed.ncbi.nlm.nih.gov/26011582/Nanci S Guest, Sudha Raj, Matthew J Landry...
https://pubmed.ncbi.nlm.nih.gov/39415400/AdventHealth
Lead Sponsor